AMCARE LIMITED

Risk Rating: LOW Justification: AMCARE LIMITED is a wholly-owned subsidiary of Convatec Holdings U.K. Ltd, a substantial established healthcare group. The company demonstrates strong regulatory compliance with no overdue filings, possesses a significant share capital base of over £5.3 million, and has maintained an active status since 1996. The primary risk stems from the opacity of its standalone financials, which is typical for subsidiary entities.

Key Concerns: * Financial Opacity: As an "Audit Exemption Subsidiary," the company files abbreviated accounts, meaning standalone solvency and liquidity metrics (such as current ratios or cash flow details) are not publicly visible. Assessment relies heavily on the parent company's financial health. * Parental Dependency: While the parent company provides a structural safety net, the entity's operational continuity and liquidity are entirely dependent on the broader Convatec group's strategy and financial stability. Any distress or restructuring at the parent level could directly impact this subsidiary. * Administrative Discrepancies: There are duplicate officer entries for James Edward Spencer Kerton and Clare Jane Bates (each holding dual director/secretary or dual director roles with slight title variations). While likely a minor administrative oversight, it raises a flag regarding internal housekeeping and record-keeping accuracy.

Positive Indicators: * Strong Corporate Backing: The PSC is Convatec Holdings U.K. Ltd, owning more than 75% of shares, holding more than 75% of voting rights, and holding the right to appoint/remove directors. This provides implicit financial backing and operational stability. * Excellent Compliance Standing: Both the annual accounts and the confirmation statement are up to date, with future due dates noted and no filings currently overdue. * Longevity and Capitalization: Incorporated in 1996, the company has a long operating history. Furthermore, the stated share capital of £5,365,486 indicates a heavily capitalized entity, suggesting it is a significant operating subsidiary rather than a dormant shell. * Experienced Governance: The board includes directors with senior corporate titles (e.g., Chief Commercial Officer, Vice President, President), indicating close integration with, and oversight from, the parent group's executive leadership.

Due Diligence Notes: * Group Financials: Review the latest consolidated annual reports of the ultimate parent (Convatec Group plc) to assess the group's overall solvency, liquidity, and strategic commitments to the UK market. * Officer Titles and SIC Alignment: Investigate the specific role of AMCARE within the group. The SIC code is 86900 (Other human health activities), yet some directors hold titles related to "Home Services Group" (an American business unit). Clarifying this operational link will confirm if the UK entity is aligned with core wound care/continence care or divergent service lines. * Housekeeping Verification: Clarify the duplicate officer entries at Companies House for Kerton and Bates to ensure beneficial ownership and control records are accurately maintained in compliance with the PSC register requirements.